MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617068627 A) filed by Daan Biotherapeutics, Inc. on June 01, 2026, for Anti-Ceacam5 Antibody And Use Thereof.
Inventors include Cho, Byoung Chul; Park, Sae Young; Yoon, Ju Gyeong; Park, Ji Young; Kim, Young Seob; and Kim, Dong Ho.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The present specification relates to an anti-CEACAM5 antibody or binding fragment thereof that specifically binds to CEACAM5 remaining on the surface of cells without binding to sCEACAM 5 present in the form of soluble CEACAM5 (sCEACAM5) in blood. Therefore, the antibody of the present invention can be delivered in an increased amount to solid tumor tissues, thus being effective as a therapeutic agent targeting cancer cells expressing CEACAM5.
Disclaimer: Curated by HT Syndication.
